NR4A1 and breast carcinoma: Hormone receptor positivity was not associated with favorable prognosis in BRCA-mutated breast cancer, whatever the type of mutated gene, but rather it displayed a tendency for worse DRFI and no difference in DFS and OS compared to hormone receptor-negative disease.